[Results obtained with the combination of trimethoprim (2,4-diamino-3[3,4,5]-pyrimidine) and sulfamethoxazole (5-methyl-3-sulfanylamidoxazole) in the treatment of acute infections of otorhinolaryngologic import].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole
I risultati dell'associazione trimetoprim (2,4-diamino-3 [3,4,5 trimetossibenzil]-pirimidina)-sulfametossazolo (5-metil-3-sulfanilamidossazolo) nel trattamento di alcune infezioni acute di pertinenza otorinolaringoiatrica.